MNZO 株価推移チャート
MNZO 収入
Exxsun Corp
$0
0%
$0
終値： Apr 27, 16:00:00 GMT-4
$0
0%
$0
プレマーケット： Apr 28, 09:00:01 GMT-4
戻る
Exxsun Corp (MNZO) 収入
主要データ
前終値
$0
始値
$0.0001
当日レンジ
$0 - $0.0001
52週レンジ
$0 - $0.0001
取引高
77.0K
平均取引高
480
配当利回り
--
1株当たり利益(TTM)
--
時価総額
$11.5K
MNZOとは何ですか？
Manzo Pharmaceuticals, Inc. engages in the provision of pharmaceutical preparations services. The company is headquartered in North York, Ontario. The company went IPO on 2001-07-11. The firm also develops its lactose intolerance product, for which it holds an exclusive patent license. The firm's primary products are dietary supplements, probiotics and natural remedies. The firm's subsidiary, Manzo Pharmaceuticals LLC (Manzo), is an alternative healthcare company with patents for a probiotic remedy for lactose intolerance. The firm also owns other products, including a remedy for babies suffering from colic and/or digestive gas. Manzo's Lacto-Freedom probiotic is a probiotic that aids in the digestion of lactose-containing foods, designed specifically for people with lactose sensitivity.
